Nancy J. Ham

Chief Executive Officer & Director at WebPT, Inc.

Nancy J. Ham

Nancy J. Ham

Chief Executive Officer & Director at WebPT, Inc.

Overview
Career Highlights

ActaMed Corp.
Sentillion, Inc.
ProxyMed, Inc.

RelSci Relationships

4482

Number of Boards

5

Birthday

1962

Age

59

Contact Data
Trying to get in touch with Nancy J. Ham? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Nancy J. Ham likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at HLM Management Co. LLC

Relationship likelihood: Strong

Managing Director at Core Capital Partners LLC

Relationship likelihood: Strong

Co-Founder at NaviNet, Inc.

Relationship likelihood: Strong

Managing Director at Ascension Ventures LLC

Relationship likelihood: Strong

Founder & Chief Medical Officer at MedVentive, Inc.

Relationship likelihood: Strong

Co-Founder at WebPT, Inc.

Relationship likelihood: Strong

Co-Founder at CHV Capital, Inc.

Relationship likelihood: Strong

Founder at Petrillo Capital

Relationship likelihood: Strong

Governor at Massachusetts Office of the Governor, Charles Baker

Relationship likelihood: Strong

Director at MedVentive, Inc.

Relationship likelihood: Strong

Paths to Nancy J. Ham
Potential Connections via
Relationship Science
You
Nancy J. Ham
Chief Executive Officer & Director at WebPT, Inc.
Education
BA in Economics

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Graduate Degree

The University of South Carolina is home to more than 200 years of history and tradition, rising from a single building in 1805 on what would become the heart of the campus, the Horseshoe. The 11 buildings that now make up the Horseshoe frame a lush lawn that is an irresistible gathering place. The university is expanding west toward the Congaree River in support of its research initiatives in nanotechnology, health sciences, Future Fuels™, the environment and information technologies. This innovation district, Innovista, includes a master plan for policy, physical infrastructure and support elements for job creation and growth in the knowledge economy. Innovista promises to be an economic catalyst that will raise the state’s per-capita income and quality of life by attracting knowledge-based businesses and high-paying jobs to an urban research university campus within a community that has a high livability appeal. Joining the flagship campus in Columbia, are four-year campuses in Aiken, Beaufort and Upstate (Spartanburg andGreenville). Four two-year campuses in Lancaster, Sumter, Salkehatchie (Allendale and Walterboro) and Union help the university cover the state. In addition, the University of South Carolina's: Columbia campus has 324 degree programs through its 14 degree-granting colleges and schools. Students have been awarded more than $16.7 million for national scholarships and fellowships since 1994. Faculty generated $238 million in funding for research, outreach and training programs in fiscal year 2012. Carolina is one of only 63 public universities listed by the Carnegie Foundation in the highest tier of research institutions in the U.S.

Memberships
Member
Current

CEO Action For Diversity & Inclusion is the CEO-driven business commitment to advance diversity and inclusion within the workplace. The company is headquartered in Chicago, IL.

Career History
Chief Executive Officer & Director
2016 - Current

WebPT, Inc. engages in the development of rehab therapy platform for enhancing patient care. Its solutions include practice management, interoperability, onboarding, and clinical supplies. The company was founded by Brad Jannenga and Heidi Jannenga in 2006 and is headquartered in Phoenix, AZ.

Industry Advisor
Current

Long River Venture invests in emerging (or secondary) market companies located in the US. The firm targets companies operating in the fields of healthcare services, healthcare IT, diagnostics, medical device. They makes follow on investments and provides financing for seed and early stage capital requirements. They invests in the range of $0.5 - $1 million and invests in companies that are raising rounds of $5 million or less. They makes co-investments and also acts as a lead or co-lead investor.

President & Chief Executive Officer
2008 - ?

MedVentive, Inc. provides healthcare and medical technology solutions for healthcare delivery networks, payers and employer coalitions. It offers medical cost containment and healthcare quality improvement solutions.MedVentive architects its solutions to deliver sophisticated data management systems and resources to leading provider organizations. The firm combining clinical data from multiple sources, MedVentive calculates clinical measures accurately, manages patient interventions efficiently, and impacts your bottom line directly.The company was founded by Jonathan M. Niloff in 1997 and is headquartered in Waltham, MA.

Boards & Committees
Independent Director
2011 - 2013

NxStage is more than just a company; we are leading the renal revolution. By our own design, we’re at the leading edge of a movement to transform renal care. To make it simpler. To make it portable. To expand treatment options for clinicians by overcoming traditional barriers. To enhance patient freedom and fulfillment. With significant breakthroughs already behind us - and others in the pipeline - NxStage is finding itself at the forefront of dramatically improved renal care, thanks to innovative yet simple therapeutic solutions that benefit patients, caregivers, and society. Our approach – and success – is inspiring patients and providers. We’re not working alone. Part of our success has come through working closely with customers, patients, industry partners, and government leaders and agencies to realize the vision of better, simpler, more accessible renal care. Our ultimate purpose is to improve the lives of renal patients, and our approach is already resulting in changed lives and industry improvements. Together, we’re changing traditional perceptions of how renal care can be delivered. NxStage innovations are expanding and improving treatment options – and giving patients and caregivers the ease and flexibility to perform treatment when they want, where they want, and how they want. We found the future of renal care because we looked for it. Thanks to forward-thinking care partners, patients, and NxStage inventors and engineers, a new era has arrived. This is great news for the estimated 2 million people around the world suffering from chronic kidney failure, or End-Stage Renal Disease (ESRD) including 571,414 in the U.S.1 It’s also good news for the hundreds of thousands of patients every year in the U.S. who suffer from acute kidney failure due to surgery, trauma, poisoning, or other emergent health situations.

Transactions
Details Hidden

MedVentive, Inc. raised money in a private placement transaction

Details Hidden

MedVentive, Inc. raised money in a private placement transaction

Details Hidden

MedVentive, Inc. raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Nancy J. Ham. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Nancy J. Ham's profile does not indicate a business or promotional relationship of any kind between RelSci and Nancy J. Ham.